Tuesday, January 6, 2015

10 Best Healthcare Technology Stocks To Buy Right Now

Popular Posts: Amazon Earnings Dent AMZN Stock, but Can’t Stop the MachineTake Buffett’s Advice: 5 Vanguard Funds to BuyThe Best Ways to Buy the Alibaba IPO Recent Posts: 3 Cheaper Alternatives to High-Priced Momo Stocks Amazon Earnings Dent AMZN Stock, but Can’t Stop the Machine When Will Fund Managers Take AAPL Stock Back? View All Posts 3 Cheaper Alternatives to High-Priced Momo Stocks

CNN Money commentator Paul La Monica tweeted the following at StockTwits July 22:

Hot India Companies To Buy Right Now: Advanced Photonix Inc (API)

Advanced Photonix, Inc. (API), incorporated in June 22, 1988, is engaged in the development and manufacture of optoelectronic devices and value-added sub-systems and systems. The Company serves a variety of global original equipment manufacturers (OEMs) in a variety of industries. API supports its customers from the initial concept and design phase of the product, through testing to full-scale production. API has two manufacturing facilities located in Camarillo, California and Ann Arbor, Michigan. API is a supplier of optoelectronic semiconductors packaged into high-speed optical receivers, custom optoelectronic subsystems and Terahertz instrumentation, serving a variety of global OEM markets. API supports the customer from the initial concept and design of the semiconductor, hybridization of support electronics, packaging and signal conditioning or processing from prototype through full-scale production and validation testing. The target markets served by it are industrial sensing/NDT, military/aerospace, telecom, medical and homeland security. On March 1, 2013, it acquired certain assets of Silonex, Inc.

The Company�� high-speed optical receivers include avalanche photodiode (APD) technology and positive-intrinsic-negative (PIN) photodiode technology based upon III-V materials, including InP, InAlAs, and GaAs. Its optoelectronic subsystems are based on its silicon large area avalanche photodiode (LAAPD), PIN photodiode, FILTRODE detectors and light emitting diode (LED) assemblies. API�� Terahertz sensor product line is targeted at the industrial homeland security and military markets. Using its fiber coupled technology and high speed Terahertz generation and detection sensors, the Company is engaged in transferring Terahertz technology from the laboratory to the factory floor for use in non-destructive testing and real time quality control.

The Company competes with First Sensor, Illinois Tool Works, JDS Uniphase, Neophotonix, U2T and Nippon Electric.

Advisors' Opinion:
  • [By Bryan Murphy]

    When most investors think of optical sensor makers, they tend to think of larger names like Honeywell International Inc.� (NYSE:HON) or Vishay Intertechnology (NYSE:VSH). And well they should. VSH is a $2 billion company, and HON is a $71.5 billion organization. The fact is, however, there are a few small cap stocks in the optical sensor space that are worth a look, and one of them is worth a very close look right now for a very clear reason... Advanced Photonix, Inc. (NYSEMKT:API).

  • [By Patricio Kehoe]

    In 2010, the company acquired privately held Nimsoft, a provider of IT performance monitoring solutions for $350 million in cash. In Sep 2010, CA signed a definitive agreement to acquire Hyperformix Inc. Recently; it acquired Layer 7 Technologies, a leading provider of Application Programming Interface (API) security and management. Furthermore, the acquisition of Arcot Systems Inc., a privately held company that provides authentication and fraud prevention software, in a move to boost its security offerings. These acquisitions have helped the firm to strengthen its cloud computing infrastructure and would also help to generate better profitability from the existing technology assets.

  • [By Monica Gerson]

    Advanced Photonix (NYSE: API) is expected to post a Q4 loss at $0.01 per share on revenue of $7.04 million.

    Sport Chalet (NASDAQ: SPCHB) is projected to post its quarterly earnings.

10 Best Healthcare Technology Stocks To Buy Right Now: iGATE Corporation(IGTE)

iGATE Corporation provides outsourced information technology (IT) and IT-enabled operations solutions and services worldwide. The company offers various services that include development and maintenance of software application; implementation and support of enterprise applications; package evaluation and implementation; re-engineering; data warehousing; business intelligence; analytics; data management and integration; software testing; IT infrastructure management; business and technology consulting; and enterprise software and systems integration, as well as quality assurance services and product engineering services. It also provides business process outsourcing, transaction processing, and customer interaction services. The company serves various industries, including insurance and healthcare, manufacturing, retail and logistics, banking and financial services, communications and utilities, media and entertainment, life sciences, and product engineering. It has India, Canada, the United States, Europe, Mexico, Singapore, Malaysia, Japan, Australia, the United Arab Emirates, South Africa, Turkey, South Korea, China, Switzerland, and the United Kingdom. iGATE Corporation was founded in 1996 and is headquartered in Fremont, California.

Advisors' Opinion:
  • [By Garrett Cook]

    Technology shares gained around 1.13 percent in Tuesday’s trading. Top gainers in the sector included iGATE (NASDAQ: IGTE), up 7.7 percent, and Camtek (NASDAQ: CAMT), up 9.8 percent.

  • [By Seth Jayson]

    iGATE (Nasdaq: IGTE  ) reported earnings on July 17. Here are the numbers you need to know.

    The 10-second takeaway
    For the quarter ended June 30 (Q2), iGATE beat slightly on revenues and beat expectations on earnings per share.

  • [By Omar Venerio]

    The company has a current ROE of 19.09%, which is higher than the industry median and the ones exhibited by CGI Group (GIB) and Amdocs (DOX). In general, analysts consider ROE ratios in the 15-20% range as representing attractive levels for investment. So for investors looking those levels or more, Teradata (TDC) could be the option. For more attractive ROE, Gartner (IT) and Igate (IGTE) have extremely good ratios. It is very important to understand this metric before investing and it is important to look at the trend in ROE over time.

  • [By Monica Gerson]

    iGATE (NASDAQ: IGTE) is estimated to report its Q3 earnings at $0.43 per share on revenue of $289.38 million.

    Safeway (NYSE: SWY) is expected to report its Q3 earnings at $0.16 per share on revenue of $8.52 billion.

10 Best Healthcare Technology Stocks To Buy Right Now: Amyris Inc.(AMRS)

Amyris, Inc., an integrated renewable products company, provides alternatives to a range of petroleum-sourced products used in specialty chemical and transportation fuel markets worldwide. The company uses its industrial synthetic biology platform to modify microorganisms, primarily yeast, to convert plant-sourced sugars into a variety of hydrocarbon molecules that serve as flexible building blocks to be used in a range of products. It is also involved in the sale of ethanol and ethanol blended gasoline to wholesale customers through a network of terminals primarily in the southeastern Unites States. In addition, the company sells farnesene or Biofene, which is used as an ingredient in a range of consumer and industrial products, including detergents, cosmetics, perfumes, and industrial lubricants. Further, it focuses on the commercialization of renewable diesel and jet fuel. The company was formerly known as Amyris Biotechnologies, Inc. and changed its name to Amyris, Inc . in June 2010. Amyris, Inc. was founded in 2003 and is headquartered in Emeryville, California.

Advisors' Opinion:
  • [By Maxx Chatsko]

    Renewable oils manufacturer Solazyme (NASDAQ: SZYM  ) got walloped after announcing a new commercialization strategy that will result in drastically reduced production volumes from facilities in Clinton, Iowa and Moema, Brazil and less revenue in 2015 and beyond than originally expected. The company's former commercialization strategy of selling massive volumes of commodity replacements relied on optimized, low-cost production and numerous customers. That stood in contrast to the strategy settled into by fellow industrial biotech Amyris (NASDAQ: AMRS  ) at the end of 2012, which relied on producing low volumes of high value products, seeding important long-term markets, driving costs down with new microbial production strains, and adopting an efficient corporate cost structure.

10 Best Healthcare Technology Stocks To Buy Right Now: OvaScience Inc (OVAS)

OvaScience, Inc., incorporated on April 5, 2011, is a life science company developing products to improve the treatment of female infertility based on recent scientific discoveries about the existence of egg precursor cells. The Company holds license from Massachusetts General Hospital (MGH) to an issued patent and various patent applications directed to methods of identifying and purifying egg precursor cells, compositions comprising egg precursor cells and methods of using egg precursor cells to treat infertility and related disorders. The Company�� product candidates are AUGMENT and OvaTure. The Company�� designs AUGMENT to treat infertility due to poor egg quality.

The Company�� first product candidate is AUGMENT, stands for autologous germline mitochondria energy transfer. It designs AUGMENT to increase the success of in vitro fertilization (IVF) by isolating fresh mitochondria from a woman's own egg precursor cells and then adding the mitochondria into the woman's egg during IVF. Its second product candidate is OvaTure. OvaTure involves the creation of mature fertilizable eggs from a woman's own egg precursor cells. If successful, this would allow women with compromised eggs due to age or other factors to undergo IVF using their own higher quality eggs.

The Company competes with Novocellus Ltd., Auxogyn, Inc, and Ovacyte LLC.

Advisors' Opinion:
  • [By John Udovich]

    On Thursday, small cap infertility stock OvaScience Inc (NASDAQ: OVAS) surged 23.63% plus shares are up 372.9% since the start of the year���meaning its worth taking a closer look at the stock along with the performance of female or reproductive health stocks the Female Health Co (NASDAQ: FHCO) and�Utah Medical Products, Inc (NASDAQ: UTMD)�along with the Vanguard Health Care ETF (NYSEARCA: VHT).

10 Best Healthcare Technology Stocks To Buy Right Now: Endeavour Silver Corporation(EXK)

Endeavour Silver Corp., a mid-cap silver mining company, focuses on the growth of its silver production, reserves, and resources in Mexico and Chile. It principally holds interests in two producing silver mines in Mexico, including the Guanacevi mine, located in Durango State; and the Guanajuato mine located in Guanajuato State. Endeavour Silver Corp. was formerly known as Endeavour Gold Corp. and changed its name on September 14, 2004. The company was founded in 1981 and is headquartered in Vancouver, Canada.

Advisors' Opinion:
  • [By Jake L'Ecuyer]

    Leading and Lagging Sectors
    In trading on Wednesday, basic materials shares were relative leaders, up on the day by about 0.27 percent. Meanwhile, top gainers in energy sector included Endeavour Silver (NYSE: EXK), with shares up 4.3 percent, and McEwen Mining (NYSE: MUX), with shares up 4.4 percent.

  • [By Jake L'Ecuyer]

    Top losers in the sector included Endeavour Silver (NYSE: EXK), off 4 percent, and Hecla Mining Co (NYSE: HL), down 3.5 percent.

    Top Headline
    Halliburton (NYSE: HAL) posted a profit in the first quarter. Halliburton swung to a quarterly profit of $622 million, or $0.73 per share, versus a year-ago loss of $18 million, or $0.02 per share. Its income from continuing operations came in at $0.73 per share. Its total revenue climbed to $7.35 billion versus $6.97 billion. However, analysts were estimating earnings of $0.72 per share on revenue of $7.26 billion.

10 Best Healthcare Technology Stocks To Buy Right Now: Regal Entertainment Group(RGC)

Regal Entertainment Group, through its subsidiaries, operates a theatre circuit in the United States. The company develops, acquires, and operates multi-screen theatres primarily in mid-sized metropolitan markets and suburban growth areas of larger metropolitan markets under the Regal Cinemas, United Artists, and Edwards brand names. As of February 13, 2012, it operated 6,614 screens in 527 theatres in 37 states and the District of Columbia. Regal Entertainment Group was founded in 2002 and is based in Knoxville, Tennessee.

Advisors' Opinion:
  • [By Sean Williams]

    Other companies, specifically in the service industry -- which pay a broad spectrum of wages -- have also been cutting jobs and/or hours in direct response to Obamacare. Movie theater chain Regal Entertainment (NYSE: RGC  ) cut thousands of workers' weekly hours to 29 or less in order to exempt itself from having to provide them health care. Companies in excess of 50 employees are required to provide access to health care for their employees and could be asked to step in and help if the cost of health care exceeds 9.5% of that employee's income. Sure, a worker whose hours are cut back from 40 to 25 may be eligible for bigger health care subsidies, but at what cost? They've just lost 15 hours of weekly pay on a regular basis as a direct cause of Obamacare's upcoming implementation, which will affect countless other aspects of their life beyond health care!

10 Best Healthcare Technology Stocks To Buy Right Now: Laboratory Corporation of America Holdings(LH)

Laboratory Corporation of America Holdings operates as an independent clinical laboratory company in the United States. The company offers a range of testing services used by the medical profession in routine testing, patient diagnosis, and in the monitoring and treatment of disease, as well as specialty testing services. Its routine tests include blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, Pap tests, HIV tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests. The company?s specialty tests and related services comprise viral load measurements, genotyping and phenotyping, and host genetic factors for managing and treating HIV infections; cytogenetic, molecular cytogenetic, biochemical, and molecular genetic tests for diagnostic genetics; oncology tests for diagnosing and monitoring certain cancers and treatments; clinical trials testing for pharmaceutical companies, which conducts clinical research trials on diag nostic assays; forensic identity testing used in criminal proceedings and parentage evaluation services, as well as testing services in reconstruction cases; allergy testing; and occupational testing for the detection of drug and alcohol abuse. Its customers include independent physicians and physician groups, hospitals, managed care organizations, governmental agencies, employers, pharmaceutical companies, and other independent clinical laboratories. The company operates a network of 51 primary laboratories and approximately 1,700 patient service centers. In addition, it delivers a co-branded electronic health records Lite solution for physician practices. The company works with university, hospital, and academic institutions, such as Duke University, The Johns Hopkins University, the University of Minnesota, and Yale University to license and commercialize new diagnostic tests. Laboratory Corporation of America Holdings was founded in 1971 and is headquartered in Burlingto n, North Carolina.

Advisors' Opinion:
  • [By Monica Wolfe]

    Over the past week Chris Davis (Trades, Portfolio) of Davis Selected Advisers added to his holdings in Laboratory Corporation of America (LH).� The guru upped his stake 21.11% by purchasing 1,666,957 shares of the company�� stock.� He bought these shares at an average price of $91.37 per share, and since then the price per share is up about 1% to $92.57 per share.

  • [By Ben Levisohn]

    Covance (CVD) has soared 26% to $100.62 after it agreed to be acquired by Laboratory Corp. of America (LH) for $6.1 billion, or about $105 a share. LabCorp has dropped 3.9% to $105.

No comments:

Post a Comment